CDTX(Delisted)
Cidara Therapeutics·NASDAQ
--
--(--)
6.21 / 10
Outperform
With a technical rating of 6.21/10, the security shows favorable technical configuration. Momentum advantages in RSI Overbought and Marubozu White are challenged by vulnerabilities in WR Overbought. Technical prognosis: cautiously optimistic.
Analysis Checks(2/3)
WR Overbought
Score3.94/10
Win Rate53.23%
Hist. Signals62
Avg Return0.91%
Score3.94/10
Win Rate53.23%
Hist. Signals62
Avg Return0.91%
Marubozu White
Score7.83/10
Win Rate68.75%
Hist. Signals16
Avg Return0.97%
Score7.83/10
Win Rate68.75%
Hist. Signals16
Avg Return0.97%
RSI Overbought
Score6.85/10
Win Rate60.00%
Hist. Signals45
Avg Return0.70%
Score6.85/10
Win Rate60.00%
Hist. Signals45
Avg Return0.70%
WR Overbought
Score3.94/10
Win Rate53.23%
Hist. Signals62
Avg Return0.91%
Score3.94/10
Win Rate53.23%
Hist. Signals62
Avg Return0.91%
RSI Overbought
Score6.85/10
Win Rate60.00%
Hist. Signals45
Avg Return0.70%
Score6.85/10
Win Rate60.00%
Hist. Signals45
Avg Return0.70%
Marubozu White
Score7.83/10
Win Rate68.75%
Hist. Signals16
Avg Return0.97%
Score7.83/10
Win Rate68.75%
Hist. Signals16
Avg Return0.97%
What is the current technical signals for CDTX?
- CDTX presents a Outperform setup with a Technical Score of 6.21/10. Key technical indicators highlight an RSI of 0.00 and a MACD of 0.00, with the trend anchored by the 50-Day SMA at 0.00.
